IL179530A0 - Novel compounds, pharmaceutical compositions containing same and methods of use for same - Google Patents

Novel compounds, pharmaceutical compositions containing same and methods of use for same

Info

Publication number
IL179530A0
IL179530A0 IL179530A IL17953006A IL179530A0 IL 179530 A0 IL179530 A0 IL 179530A0 IL 179530 A IL179530 A IL 179530A IL 17953006 A IL17953006 A IL 17953006A IL 179530 A0 IL179530 A0 IL 179530A0
Authority
IL
Israel
Prior art keywords
same
methods
pharmaceutical compositions
compositions containing
novel compounds
Prior art date
Application number
IL179530A
Other languages
English (en)
Original Assignee
Univ Johns Hopkins
Fasgen Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins, Fasgen Llc filed Critical Univ Johns Hopkins
Publication of IL179530A0 publication Critical patent/IL179530A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
IL179530A 2004-05-26 2006-11-23 Novel compounds, pharmaceutical compositions containing same and methods of use for same IL179530A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57463904P 2004-05-26 2004-05-26
PCT/US2005/018443 WO2005117590A2 (en) 2004-05-26 2005-05-25 Novel compounds, pharmaceutical compositions containing same, and methods of use for same

Publications (1)

Publication Number Publication Date
IL179530A0 true IL179530A0 (en) 2007-05-15

Family

ID=35463277

Family Applications (1)

Application Number Title Priority Date Filing Date
IL179530A IL179530A0 (en) 2004-05-26 2006-11-23 Novel compounds, pharmaceutical compositions containing same and methods of use for same

Country Status (13)

Country Link
US (1) US20090005435A1 (cg-RX-API-DMAC7.html)
EP (1) EP1758577A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008500363A (cg-RX-API-DMAC7.html)
KR (1) KR20070095754A (cg-RX-API-DMAC7.html)
CN (1) CN101022792A (cg-RX-API-DMAC7.html)
AU (1) AU2005249437A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0510397A (cg-RX-API-DMAC7.html)
CA (1) CA2568639A1 (cg-RX-API-DMAC7.html)
IL (1) IL179530A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06013687A (cg-RX-API-DMAC7.html)
RU (1) RU2006146051A (cg-RX-API-DMAC7.html)
WO (1) WO2005117590A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200700024B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007014248A2 (en) * 2005-07-26 2007-02-01 Johns Hopkins University Method of reducing food intake
AU2007300627B2 (en) * 2006-09-22 2012-02-16 Merck Sharp & Dohme Corp. Method of treatment using fatty acid synthesis inhibitors
KR101640263B1 (ko) * 2007-10-05 2016-07-15 젠자임 코포레이션 세라마이드 유도체로 다낭성 신장질환을 치료하는 방법
WO2010118324A2 (en) 2009-04-09 2010-10-14 Nuclea Biotechnologies, LLC Antibodies against fatty acid synthase
WO2014039769A1 (en) * 2012-09-07 2014-03-13 Janssen Pharmaceutica Nv Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
CA2968288A1 (en) 2014-11-20 2016-05-26 Vib Vzw Means and methods for treatment of early-onset parkinson's disease
CN114980740A (zh) 2020-01-23 2022-08-30 巴斯夫欧洲公司 用于农业化学配制剂的新型添加剂
CN116507203B (zh) 2020-10-27 2026-08-07 巴斯夫欧洲公司 农药微乳剂组合物
CA3207197A1 (en) 2021-02-05 2022-08-11 Murat Mertoglu Liquid herbicidal compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3427847A1 (de) * 1983-12-09 1985-06-13 Bayer Ag, 5090 Leverkusen Thiolan-2,4-dion-3-carboxamide
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass
MXPA04007556A (es) * 2002-02-08 2005-12-05 Univ Johns Hopkins Med Estimulacion de cpt-1 como medio para reducir peso.
US7649012B2 (en) * 2002-07-09 2010-01-19 Fasgen, Inc. Compounds, pharmaceutical compositions containing same, and methods of use for same

Also Published As

Publication number Publication date
WO2005117590A3 (en) 2006-07-27
WO2005117590A2 (en) 2005-12-15
ZA200700024B (en) 2008-06-25
JP2008500363A (ja) 2008-01-10
AU2005249437A1 (en) 2005-12-15
RU2006146051A (ru) 2008-07-10
EP1758577A2 (en) 2007-03-07
BRPI0510397A (pt) 2007-11-13
US20090005435A1 (en) 2009-01-01
EP1758577A4 (en) 2010-05-05
CA2568639A1 (en) 2005-12-15
MXPA06013687A (es) 2007-10-18
CN101022792A (zh) 2007-08-22
KR20070095754A (ko) 2007-10-01

Similar Documents

Publication Publication Date Title
IL190218A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
IL238308A0 (en) Pharmaceutical preparations containing azalastine
ZA200703277B (en) Novel pyrimidine compounds, process for their preparation and compositions containing them
IL179754A0 (en) Pyrazole derivatives, compositions containing such compounds and methods of use
IL210756A0 (en) Carbostyril compound, process for their preparation and pharmaceutical compositions containing them
IL173930A0 (en) Pharmaceutical compositions containing forms of r-baclofen
IL183986A0 (en) Pharmaceutical compounds and compositions
EP1814885A4 (en) NOVEL HETEROCYCLIC BICYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SAME
IL179757A0 (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
IL179933A0 (en) Pharmaceutical compositions containing proteosome based compositions
IL190477A0 (en) Pyrazole derivatives, compositions containing such compounds and methods of use
IL187713A0 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
IL176988A0 (en) Pharmaceutical compositions containing amino alcohol compounds
IL175300A0 (en) Indirubin-type compounds, compositions, and methods for their use
SI1720544T1 (sl) Novi azabicikliäśni derivati, postopek za njihovopripravo in farmacevtski sestavki, ki jih vsebujejo
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
ZA200500203B (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
PL1951663T3 (pl) Pochodne (R)-aryloalkiloaminowe i zawierające je kompozycje farmaceutyczne
ZA200606606B (en) Substituted Azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
IL198634A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
EP1797078A4 (en) BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THESE DERIVATIVES, PREPARATION AND USES THEREOF
IL179697A0 (en) Variants of unc5h2, their preparation and pharmaceutical compositions containing them
IL174589A0 (en) Pharmaceutical compositions containing tetrahydrobiopterin
EP1797074A4 (en) COMPOUNDS, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND APPLICATIONS THEREOF IIII
GB2404856B (en) Stable pharmaceutical composition of rabeprazole